EUVIMEDEUVIMED entdecken
Open Access

Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation

Toshiaki Iba, Julie Helms, Matthew D Neal, Jerrold H Levy

Journal of Thrombosis and Haemostasis · 2023-12 · 21 (12) · 3360-3370

DOI: 10.1016/j.jtha.2023.05.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023-12. Verfasst von Toshiaki Iba und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Electronic address: toshiiba@juntendo.a…. Hauptthemen laut MEDLINE: Disseminated Intravascular Coagulation, Blood Coagulation Disorders, Sepsis. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Takeda Pharmaceutical Company, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disseminated intravascular coagulation can occur due to different causes but commonly following sepsis. Trauma-induced coagulopathy (TIC) occurs on hospital arrival in approximately 25% of seriously injured patients who initially presents with impaired hemostasis and a bleeding phenotype that can later progress to a prothrombotic phase. Following traumatic injury, ineffective hemostasis is driven by massive blood loss, tissue damage, and hyperfibrinolysis. This initial impaired hemostasis continues until surgical or other management strategies not only to stop the causes of hemorrhage but also progresses to a prothrombotic and hypofibrinolytic state, also termed fibrinolytic shutdown. Prothrombotic progression is also promoted by inflammatory mediator release, endothelial injury, and platelet dysregulation, which is commonly seen in sepsis with increased mortality. Unlike TIC, the early phase of sepsis is frequently complicated by multiorgan dysfunction described as sepsis-induced coagulopathy (SIC) that lacks a hemorrhagic phase. The phenotypes of SIC and TIC are different, especially in their initial presentations; however, patients who survive TIC may also develop subsequent infections and potentially sepsis and SIC. Although the pathophysiology of SIC and TIC are different, endothelial injury, dysregulated fibrinolysis, and coagulation abnormalities are common. Management includes treatment of the underlying cause, tissue injury vs infection is critical, and supportive therapies, such as hemostatic resuscitation and circulatory support are essential, and adjunct therapies are recommended in guidelines. Based on clinical studies and certain guidelines, additional therapies include tranexamic acid in the limited timing of initial traumatic injury and anticoagulants, such as antithrombin and recombinant thrombomodulin in disseminated intravascular coagulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disseminated Intravascular CoagulationBlood Coagulation DisordersSepsisHumansHemostasisFibrinolysisHemorrhageAnticoagulants

Stichwörter der Autor:innen

anticoagulantcoagulopathydisseminated intravascular coagulationendothelial cellfibrinolysis

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Electronic address: toshiiba@juntendo.ac.jp.
  • Strasbourg University (UNISTRA); Strasbourg University Hospital, Medical Intensive Care Unit - NHC; INSERM (French National Institute of Health and Medical Research), Strasbourg, France.
  • Trauma and Transfusion Medicine Research Center, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: https://twitter.com/JerroldLevy.

Förderung

  • NIGMS NIH HHS
  • Takeda Pharmaceutical Company
  • National Institutes of Health
  • CSL Behring

Zitieren

APA

Iba, T., Helms, J., Neal, M. D., & Levy, J. H. (2023). Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation. Journal of Thrombosis and Haemostasis, 21(12), 3360-3370. https://doi.org/10.1016/j.jtha.2023.05.028

Vancouver

Iba T, Helms J, Neal MD, Levy JH. Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation. Journal of Thrombosis and Haemostasis. 2023;21(12):3360-3370. doi:10.1016/j.jtha.2023.05.028

BibTeX
@article{Iba2023,
  author = {Iba, Toshiaki and Helms, Julie and Neal, Matthew D and Levy, Jerrold H},
  title = {Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2023},
  volume = {21},
  number = {12},
  pages = {3360--3370},
  doi = {10.1016/j.jtha.2023.05.028}
}
Kostenlos starten →